ObjectiveHealth Named Winner in 2022 Artificial Intelligence Excellence Awards
Philadelphia, PA–March 22,2021– The Business Intelligence Group announced today that ObjectiveHealth, the integrated research and digital health services company, was named a winner in its Artificial Intelligence Excellence Awards program for their proprietary technology platform, ObjectiveScreen.
ObjectiveScreen is a proprietary AI technology platform created by ObjectiveHealth to extract electronic healthcare data and create AI models that identify, prequalify and rank patients for clinical trials optimizing trial performance and outcomes. ObjectiveScreen machine learning capabilities makes data inferences and continually improves algorithms over time, leading to more ideal patient identification for each succeeding trial.
“The adoption of artificial intelligence in digital health technologies and real-world data analysis, is critical in transforming the future of clinical research and improving efficiencies of complex trials,” said Colleen Hoke, co-founder and chief executive officer of ObjectiveHealth. “We are honored to be named as an Artificial Intelligence Excellence Awards winner in the Diagnosis category for our work in ObjectiveScreen.”
ObjectiveScreen has identified thousands of patients with chronic diseases who are at-risk for, but undiagnosed. ObjectiveHealth anticipates expanding their efforts further by risk stratifying patients for diseases like cirrhosis, inflammatory bowel disease, and colorectal cancer.
“We are so proud to name ObjectiveHealth as a winner in our inaugural Artificial Intelligence Excellence Awards program,” said Maria Jimenez, chief nominations officer for Business Intelligence Group. “It was clear to our judges that ObjectiveHealth was using AI to improve the lives of their customers and employees. Congratulations to the entire team!”
ObjectiveHealth is a leading integrated research provider partnering with physicians and healthcare organizations to establish advanced infrastructure for research programs. The company takes an innovative approach to research that aims to improve patient outcomes at the point-of-care. Utilizing proprietary technology, processes and trained on-site personnel, ObjectiveHealth delivers significant advances in the conduct of clinical research, benefiting clients and partners while providing broader care options for patients. With over 20 partnered programs across 14 states and over 300 providers, ObjectiveHealth is poised for continued growth due to the realized value of their healthcare solutions for all stakeholders. To learn more, visit: www.objective.health.
About Business Intelligence Group
The Business Intelligence Group was founded with the mission of recognizing true talent and superior performance in the business world. Unlike other industry award programs, these programs are judged by business executives having experience and knowledge. The organization’s proprietary and unique scoring system selectively measures performance across multiple business domains and then rewards those companies whose achievements stand above those of their peers. To learn more, visit www.bintelligence.com